Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Articles published by GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Davis Commodities Evaluates Premium Nutrition Vertical Within USD 97 Billion Specialty Food Ingredients Market
November 07, 2025
From
DAVIS COMMODITIES LIMITED
Via
GlobeNewswire
Tickers
DTCK
Quantum Leap Energy LLC Announces Private Placement of Convertible Notes Led by American Ventures LLC
November 07, 2025
From
ASP Isotopes Inc.
Via
GlobeNewswire
Tickers
ASPI
Thai vocational education representatives visit Guangxi Financial Vocational College, jointly discussing a new blueprint for vocational education
November 07, 2025
From
Guangxi Financial Vocational College
Via
GlobeNewswire
GBank Financial Holdings Inc. and GBank Appoint Hilary R. Sledge-Sarnor as Executive Vice President, General Counsel, and Corporate Secretary
November 07, 2025
From
GBank Financial Holdings Inc.
Via
GlobeNewswire
Tickers
GBFH
Edible Garden Schedules Third Quarter 2025 Financial Results and Business Update Conference Call
November 07, 2025
From
Edible Garden AG Incorporated
Via
GlobeNewswire
Tickers
EDBL
EDBLW
Just Published! A New Book that Promises Inspiration to Transform Lives with Love and Kindness: Kennedy's Inspiring Story
November 07, 2025
From
Palmetto Publishing
Via
GlobeNewswire
Xilio Therapeutics Announces Late-Breaking Phase 2 Data for Vilastobart in Patients with MSS mCRC and High Plasma Tumor Mutational Burden at Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting
November 07, 2025
From
Xilio Therapeutics, Inc.
Via
GlobeNewswire
Tickers
XLO
Lincoln Tech to Expand Presence in Texas with New Rowlett Campus
November 07, 2025
From
Lincoln Tech
Via
GlobeNewswire
Tickers
LINC
Xilio Therapeutics Highlights Portfolio of Differentiated Masked Immunotherapies at Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting
November 07, 2025
From
Xilio Therapeutics, Inc.
Via
GlobeNewswire
Tickers
XLO
Changes in Nokia Corporation's own shares
November 07, 2025
From
Nokia Oyj
Via
GlobeNewswire
Trump Media Reports Third Quarter 2025 Results
November 07, 2025
From
Trump Media & Technology Group
Via
GlobeNewswire
Tickers
DJT
Coherus Oncology Presents at SITC Clinical Multiomic Biomarker Data for CHS-114, a Highly Selective anti-CCR8 Cytolytic Antibody
November 07, 2025
From
Coherus Oncology, Inc.
Via
GlobeNewswire
Tickers
CHRS
Elicio Therapeutics Reports Robust, Cytolytic mKRAS-Specific T Cell Responses Across Diverse Patient HLA in Ongoing Phase 2 AMPLIFY-7P Trial of ELI-002 7P and New ELI-004 Preclinical Data at SITC
November 07, 2025
From
Elicio Therapeutics Inc.
Via
GlobeNewswire
Tickers
ELTX
Werewolf Therapeutics Presents Data Expanding Its PREDATOR® Platform at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
November 07, 2025
From
Werewolf Therapeutics, Inc.
Via
GlobeNewswire
Tickers
HOWL
NextNRG Reports Preliminary October 2025 Revenue Growth of 196% Year-Over-Year
November 07, 2025
From
NextNRG, Inc.
Via
GlobeNewswire
Tickers
NXXT
RFN's SX-E60: A New Era of Control in Electric Off-Roading Explored at EICMA Roundtable
November 07, 2025
From
Zhejiang Apollo Sports Technology Co., Ltd.
Via
GlobeNewswire
Tizona Therapeutics Presents Clinical Translational Evidence of Dual Innate and Adaptive Immune Activation with TTX-080, a First-in-Class HLA-G Antagonist, in Patients with Advanced Solid Tumors at SITC 2025
November 07, 2025
From
Tizona Therapeutics Inc
Via
GlobeNewswire
ETC’s Commercial/Industrial Unit Awarded Contracts Totaling $9.1 Million
November 07, 2025
From
Environmental Tectonics Corporation
Via
GlobeNewswire
Tickers
ETCC
T-knife Therapeutics Presents Preclinical Data on PRAME-Targeted TK-6302 Highlighting its Potential as a Promising, Category-leading Therapy at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 07, 2025
From
T-knife Therapeutics
Via
GlobeNewswire
MiNK Therapeutics Reports Durable Responses and Immune Reactivation with Allo-iNKT Cell Therapy agenT-797 in PD-1–Refractory Solid Tumors at SITC 2025
November 07, 2025
From
MiNK Therapeutics
Via
GlobeNewswire
Tickers
INKT
Fullmark Energy Announces Completion of Redwood Projects Portfolio with Commercial Operations of 65MW San Jacinto Energy Storage Project
November 07, 2025
From
Fullmark Energy
Via
GlobeNewswire
Wearable Devices Expands into Asia’s Tech Powerhouse: Secures Exclusive Distribution Agreement in South Korea
November 07, 2025
From
Wearable Devices Ltd.
Via
GlobeNewswire
Tickers
WLDS
WLDSW
Legrand Acquires Avtron Power Solutions, a Global Provider of Load Banks & Power Quality Solutions
November 07, 2025
From
Legrand North & Central America
Via
GlobeNewswire
BioAge Labs to Present at Jefferies Global Healthcare Conference in London
November 07, 2025
From
BioAge Labs, Inc.
Via
GlobeNewswire
Tickers
BIOA
CTS Corporation Declares a Dividend and Share Repurchase Program
November 07, 2025
From
CTS Corporation
Via
GlobeNewswire
Tickers
CTS
Flare Therapeutics Presents Correlative Biomarker Analysis from the FX-909 Phase 1A Clinical Study at SITC 2025 40th Anniversary Annual Meeting
November 07, 2025
From
Flare Therapeutics Inc.
Via
GlobeNewswire
NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Data Updates from Ongoing NEO100-1 Phase 1/2a Clinical Trial and Compassionate Use Program
November 07, 2025
From
NeOnc Technologies Holdings, Inc.
Via
GlobeNewswire
Tickers
NTHI
EQ Appoints Nicholas Nichols as Executive Vice President of Mutual Funds
November 07, 2025
From
EQ
Via
GlobeNewswire
Creative Realities Closes Acquisition of Cineplex Digital Media
November 07, 2025
From
Creative Realities
Via
GlobeNewswire
Tickers
CREX
TSX:CGX
H/Advisors Abernathy Named Private Equity Wire’s U.S. PR & Communications Firm of the Year in 2025 for Second Consecutive Year
November 07, 2025
From
H/Advisors Abernathy
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.